Related references
Note: Only part of the references are listed.Identification of neoantigens for individualized therapeutic cancer vaccines
Franziska Lang et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity
Jung-Eun Kim et al.
FRONTIERS IN IMMUNOLOGY (2021)
Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01
Se-Young Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy et al.
FRONTIERS IN IMMUNOLOGY (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells
Keunok Jung et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1
Zachary Maben et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
David G. Millar et al.
NATURE BIOTECHNOLOGY (2020)
Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant-driven tumor growth
Seung-Min Shin et al.
SCIENCE ADVANCES (2020)
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Vid Leko et al.
CANCER CELL (2020)
Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo
Cornelia Fischer et al.
MABS (2020)
Repurposing CD8+T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
Shashi Gujar et al.
ONCOIMMUNOLOGY (2020)
Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy
Pamela C. Rosato et al.
NATURE COMMUNICATIONS (2019)
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
Anne Mansson Kvarnhammar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer
Ye-Jin Kim et al.
CANCER LETTERS (2019)
Engineering of a tumor cell-specific, cytosol-penetrating antibody with high endosomal escape efficacy
Ji-Sun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy
Qiyue Hu et al.
SCIENTIFIC REPORTS (2018)
Cytomegalovirus-Specific CD8+T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
Thomas Poiret et al.
FRONTIERS IN IMMUNOLOGY (2018)
Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells
Keunok Jung et al.
ONCOIMMUNOLOGY (2018)
The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer
Xiao-Hua Luo et al.
IMMUNOLOGY (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01 BREAKING CONFINEMENT
Soumya G. Remesh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression
Dan A. Erkes et al.
JOURNAL OF IMMUNOLOGY (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
Seung-Min Shin et al.
NATURE COMMUNICATIONS (2017)
Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance
Seung-Joo Hyun et al.
FRONTIERS IN IMMUNOLOGY (2017)
Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4+ and CD8+ T Cell Responses against Mouse Cytomegalovirus Infection
Eleni Panagioti et al.
FRONTIERS IN IMMUNOLOGY (2017)
Exploring the Role of RGD-Recognizing Integrins in Cancer
Markus Nieberler et al.
CANCERS (2017)
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
Tilman Schlothauer et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
T cell responses to cytomegalovirus
Paul Klenerman et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Committing Cytomegalovirus-Specific CD8 T Cells to Eliminate Tumor Cells by Bifunctional Major Histocompatibility Class I Antibody Fusion Molecules
Martina Schmittnaegel et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma
Andrea Schuessler et al.
CANCER RESEARCH (2014)
Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells
Smita K. Nair et al.
CLINICAL CANCER RESEARCH (2014)
A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells
Dong-Ki Choi et al.
MABS (2014)
Pathways of Antigen Processing
Janice S. Blum et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8+ T Cell-mediated Killing
Tae Heung Kang et al.
MOLECULAR THERAPY (2013)
An Anti-Nucleic Acid Antibody Delivers Antigen to the Cross-Presentation Pathway in Dendritic Cells and Potentiates Therapeutic Antitumor Effects
Chuong D. Pham et al.
JOURNAL OF IMMUNOLOGY (2012)
The Efficiency of Human Cytomegalovirus pp65495-503 CD8+ T Cell Epitope Generation Is Determined by the Balanced Activities of Cytosolic and Endoplasmic Reticulum-Resident Peptidases
Sabrina Urban et al.
JOURNAL OF IMMUNOLOGY (2012)
Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells
Shan Wan et al.
PLOS ONE (2012)
Promiscuous binding of extracellular peptides to cell surface class I MHC protein
Herman N. Eisen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Michael J. Cannon et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Crystallization and preliminary X-ray crystallographic characterization of a public CMV-specific TCR in complex with its cognate antigen
Jean-Baptiste Reiser et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2009)
OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T cells: A CD4-dependent mechanism
Ian R. Humphreys et al.
JOURNAL OF IMMUNOLOGY (2007)
Post-proteasomal antigen processing for major histocompatibility complex class I presentation
KL Rock et al.
NATURE IMMUNOLOGY (2004)
Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals
N Khan et al.
JOURNAL OF IMMUNOLOGY (2002)
Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides
AXY Mo et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
